Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Utah Medical Products, Inc. UTMD

Growth Flags show if company had growth for consecutive years

Financial statements are limited to most recent four years or quarters for non-powerpack users

Ten years worth of data (where available), most important trends and XLS exports are available for our Powerpack users.
An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.
Dec '25
Dec '24
Dec '23
Dec '22
Dec '21
Dec '20
Dec '19
Dec '18
Dec '17
Dec '16
Revenue
38.52
40.90
50.22
52.28
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Revenue Growth
(5.83%)
(18.56%)
(3.93%)
6.58%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Cost of Revenue
16.52
16.76
20.19
20.09
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Gross Profit
22.00
24.14
30.04
32.20
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
R&D Expenses
0.67
0.81
0.56
0.49
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
SG&A Expenses
9.93
9.74
12.70
11.91
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Operating Income
11.40
13.59
16.78
19.79
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Non-operating Income/Expense
2.71
3.21
3.31
0.87
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Non-operating Interest Expenses
0.66
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBT
14.11
16.80
20.09
20.66
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Income Tax Provision
2.82
2.93
3.45
4.19
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Income after Tax
11.29
13.87
16.64
16.47
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Dividends (Preferred)
0.00
0.00
‡‡‡
‡‡‡
‡‡‡
Net Income Common
11.29
13.87
16.64
16.47
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Basic)
3.48
3.96
4.57
4.52
‡‡‡‡
‡‡‡‡
‡‡‡‡
‡‡‡‡
‡‡‡‡
‡‡‡‡
EPS (Diluted)
3.48
3.96
4.57
4.52
‡‡‡‡
‡‡‡‡
‡‡‡‡
‡‡‡‡
‡‡‡‡
‡‡‡‡
Shares (Basic, Weighted)
3.24
3.50
3.63
3.64
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Shares (Diluted, Weighted)
3.24
3.50
3.64
3.64
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Gross Margin
57.12%
59.03%
59.81%
61.58%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBIT Margin
29.60%
33.23%
33.40%
37.85%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBT margin
36.63%
41.08%
40.00%
39.52%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Net Profit Margin
29.30%
33.92%
33.12%
31.51%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Free Cash Flow Margin
37.18%
35.75%
43.09%
38.88%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBITDA
14.41
16.44
23.15
26.87
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBIT
11.40
13.59
16.78
19.79
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Income from Continuous Operations
11.29
13.87
16.64
16.47
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Consolidated Net Income/Loss
11.29
13.87
16.64
16.47
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Basic, from Continuous Ops)
3.48
3.96
4.58
4.53
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Basic, Consolidated)
3.48
3.96
4.58
4.53
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Diluted, from Cont. Ops)
3.48
3.96
4.57
4.52
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Shares (Diluted, Average)
3.24
3.50
3.64
3.64
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Diluted, Consolidated)
3.48
3.96
4.57
4.52
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBITDA Margin
37.41%
40.19%
46.08%
51.40%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Operating Cash Flow Margin
38.14%
36.26%
44.36%
40.45%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us